THERAPEUTIC DRUG MONITORING OF INFLIXIMAB IN INFLAMMATORY RHEUMATIC DISEASES: REAL-LIFE DATA IN A COHORT OF PATIENTS

被引：0
|
作者：
Martin Lopez, M. [1 ]
Molina Esteban, N. [1 ]
Cabrera, O. [2 ]
Pablos, J. L. [1 ]
机构：
[1] Hosp Univ 12 Octubre, Inst Invest i12, Rheumatol, Madrid, Spain
[2] Hosp Univ 12 Octubre, Immunol, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Spondyloarthritis; bDMARD; Rheumatoid arthritis;
D O I：
10.1136/annrheumdis-2023-eular.4892
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0964
引用
收藏
页码：1700 / 1701
页数：2
相关论文
共 50 条
  • [41] Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease-Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics
    Little, Robert D.
    Ward, Mark G.
    Wright, Emily
    Jois, Asha J.
    Boussioutas, Alex
    Hold, Georgina L.
    Gibson, Peter R.
    Sparrow, Miles P.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [42] Drug maintenance of a second tumor necrosis factor alpha inhibitor in spondyloarthritis patients: A real-life multicenter study
    Krajewski, Faustine
    Andras, Lucia
    Pereira-Gillion, Celine
    Goupille, Philippe
    Salliot, Carine
    JOINT BONE SPINE, 2019, 86 (06) : 761 - 767
  • [43] Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study
    Gustavo Nogueira Schincariol Vicente
    Ivânio Alves Pereira
    Gláucio Ricardo Werner de Castro
    Licia Maria Henrique da Mota
    Ana Paula Carnieletto
    Dhara Giovanna Santin de Souza
    Fabiana Oenning da Gama
    Ana Beatriz Vargas Santos
    Cleandro Pires de Albuquerque
    Manoel Barros Bértolo
    Paulo Louzada Júnior
    Rina Dalva Neubarth Giorgi
    Sebastião Cezar Radominski
    Maria Fernanda Brandão Resende Guimarães
    Karina Rossi Bonfiglioli
    Maria de Fátima Lobato da Cunha Sauma
    Claiton Viegas Brenol
    Geraldo da Rocha Castelar Pinheiro
    Advances in Rheumatology, 61
  • [44] Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study
    Vicente, Gustavo Nogueira Schincariol
    Pereira, Ivanio Alves
    de Castro, Glaucio Ricardo Werner
    da Mota, Licia Maria Henrique
    Carnieletto, Ana Paula
    de Souza, Dhara Giovanna Santin
    da Gama, Fabiana Oenning
    Santos, Ana Beatriz Vargas
    de Albuquerque, Cleandro Pires
    Bertolo, Manoel Barros
    Louzada Junior, Paulo
    Giorgi, Rina Dalva Neubarth
    Radominski, Sebastiao Cezar
    Guimaraes, Maria Fernanda Brandao Resende
    Bonfiglioli, Karina Rossi
    Sauma, Maria de Fatima Lobato da Cunha
    Brenol, Claiton Viegas
    da Rocha Castelar Pinheiro, Geraldo
    ADVANCES IN RHEUMATOLOGY, 2021, 61 (01)
  • [45] Abatacept or infliximab for patients with rheumatoid arthritis and inadequate response to methotrexate: an Italian trial-based and real-life cost-consequence analysis
    Benucci, M.
    Stam, W. B.
    Gilloteau, I.
    Sennfaelt, K.
    Leclerc, A.
    Maetzel, A.
    Lucioni, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) : 575 - 583
  • [46] Relapse rates and predictors for relapse in a real-life cohort of IBD patients after discontinuation of anti-TNF therapy
    Bots, Steven J.
    Kuin, Sabine
    Ponsioen, Cyriel Y.
    Gecse, Krisztina B.
    Duijvestein, Marjolijn
    D'Haens, Geert R.
    Lowenberg, Mark
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (03) : 281 - 288
  • [47] Assessment of effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting for treatment of patients with active rheumatoid arthritis or ankylosing spondylitis
    Codreanu, Catalin
    Sirova, Klara
    Jarosova, Katerina
    Batalov, Anastas
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (10) : 1763 - 1769
  • [48] Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort
    Gentileschi, Stefano
    Gaggiano, Carla
    Damiani, Arianna
    Coccia, Carmela
    Bernardini, Pamela
    Cazzato, Massimiliano
    D'Alessandro, Francesco
    Vallifuoco, Giulia
    Terribili, Riccardo
    Bardelli, Marco
    Baldi, Caterina
    Cantarini, Luca
    Mosca, Marta
    Frediani, Bruno
    Guiducci, Serena
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [49] Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study
    Voshaar, Marieke
    Vriezekolk, Johanna
    van Dulmen, Sandra
    van den Bemt, Bart
    van de Laar, Mart
    BMC MUSCULOSKELETAL DISORDERS, 2016, 17
  • [50] Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study
    Marieke Voshaar
    Johanna Vriezekolk
    Sandra van Dulmen
    Bart van den Bemt
    Mart van de Laar
    BMC Musculoskeletal Disorders, 17
12345